These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9700480)

  • 1. Relation between apolipoprotein e phenotype and the changes in lipids during tamoxifen treatment.
    Hozumi Y; Kawano M; Saito T; Miyata M
    Endocr J; 1998 Apr; 45(2):255-9. PubMed ID: 9700480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe hypertriglyceridemia caused by tamoxifen-treatment after breast cancer surgery.
    Hozumi Y; Kawano M; Miyata M
    Endocr J; 1997 Oct; 44(5):745-9. PubMed ID: 9466333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein E phenotypes and plasma lipids in young and middle-aged subjects.
    Eto M; Watanabe K; Iwashima Y; Morikawa A; Oshima E; Sekiguchi M; Ishii K
    Tohoku J Exp Med; 1986 Jan; 148(1):25-34. PubMed ID: 3705062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of apolipoprotein E3/4 phenotype on postprandial triglycerides and retinyl palmitate metabolism in plasma from hyperlipidemic subjects in Japan.
    Kobayashi J; Saito Y; Taira K; Hikita M; Takahashi K; Bujo H; Morisaki N; Saito Y
    Atherosclerosis; 2001 Feb; 154(3):539-46. PubMed ID: 11257254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of low-dose pravastatin on plasma levels of lipids and apolipoproteins in Japanese type II hyperlipoproteinemic subjects with apolipoprotein E phenotype E3/2, E3/3, and E4/3.
    Kobayashi T; Homma Y
    J Clin Pharmacol; 2001 Oct; 41(10):1055-8. PubMed ID: 11583472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reciprocal effects of apolipoprotein E alleles (epsilon 2 and epsilon 4) on plasma lipid levels in normolipidemic subjects.
    Eto M; Watanabe K; Ishii K
    Clin Genet; 1986 Jun; 29(6):477-84. PubMed ID: 3461894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E polymorphism, serum lipids, myocardial infarction and severity of angiographically verified coronary artery disease in men and women.
    Lehtinen S; Lehtimäki T; Sisto T; Salenius JP; Nikkilä M; Jokela H; Koivula T; Ebeling F; Ehnholm C
    Atherosclerosis; 1995 Apr; 114(1):83-91. PubMed ID: 7605379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of probucol on plasma lipids and lipoproteins in familial hypercholesterolemic patients with and without apolipoprotein E4.
    Eto M; Sato T; Watanabe K; Iwashima Y; Makino I
    Atherosclerosis; 1990 Sep; 84(1):49-53. PubMed ID: 2248620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged postprandial responses of lipids and apolipoproteins in triglyceride-rich lipoproteins of individuals expressing an apolipoprotein epsilon 4 allele.
    Bergeron N; Havel RJ
    J Clin Invest; 1996 Jan; 97(1):65-72. PubMed ID: 8550852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of tamoxifen on serum lipid metabolism.
    Hozumi Y; Kawano M; Saito T; Miyata M
    J Clin Endocrinol Metab; 1998 May; 83(5):1633-5. PubMed ID: 9589669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between apolipoprotein E polymorphism, menopausal symptoms, and serum lipids during hormone replacement therapy.
    Somekawa Y; Wakabayashi A
    Eur J Obstet Gynecol Reprod Biol; 1998 Aug; 79(2):185-91. PubMed ID: 9720839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of apolipoprotein E polymorphism on the tracking of childhood levels of serum lipids and apolipoproteins over a 6-year period. The Bogalusa Heart Study.
    Srinivasan SR; Ehnholm C; Wattigney WA; Berenson GS
    Atherosclerosis; 1996 Nov; 127(1):73-9. PubMed ID: 9006807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of apolipoprotein E between apo B- and non apo B-containing lipoproteins according to apo E phenotype.
    Luc G; Ducimetiere P; Bard JM; Arveiler D; Evans A; Cambien F; Fruchart JC; Fievet C
    Atherosclerosis; 1997 Jun; 131(2):257-62. PubMed ID: 9199280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein E4 phenotype increases non-fasting serum triglyceride concentration in infants - the STRIP study.
    Tammi A; Rönnemaa T; Viikari J; Jokinen E; Lapinleimu H; Ehnholm C; Simell O
    Atherosclerosis; 2000 Sep; 152(1):135-41. PubMed ID: 10996348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Severe hypertriglyceridemia induced by tamoxifen].
    Taira M; Takasu N; Komiya I
    Nihon Ronen Igakkai Zasshi; 1998 Nov; 35(11):858-60. PubMed ID: 10064974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein E phenotypes in patients with gout: relation with hypertriglyceridaemia.
    Moriwaki Y; Yamamoto T; Takahashi S; Tsutsumi Z; Higashino K
    Ann Rheum Dis; 1995 May; 54(5):351-4. PubMed ID: 7794039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triglyceride-rich lipoproteins from apolipoprotein E3/2 subjects with hypertriglyceridemia enhance cholesteryl ester synthesis in human macrophages.
    Saito M; Eto M; Makino I
    Atherosclerosis; 1997 Feb; 129(1):73-7. PubMed ID: 9069520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial hypercholesterolemia and apolipoprotein E4.
    Eto M; Watanabe K; Chonan N; Ishii K
    Atherosclerosis; 1988 Aug; 72(2-3):123-8. PubMed ID: 3214464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma levels of lathosterol and phytosterols in relation to age, sex, anthropometric parameters, plasma lipids, and apolipoprotein E phenotype, in 160 Dutch families.
    Kempen HJ; de Knijff P; Boomsma DI; van der Voort HA; Gevers Leuven JA; Havekes L
    Metabolism; 1991 Jun; 40(6):604-11. PubMed ID: 1865824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of moderate hypertriglyceridemia with apolipoprotein E phenotype E4/3.
    Kojima S; Homma Y; Sakane H; Kobayashi T; Ozawa H; Okajima Y
    Tokai J Exp Clin Med; 1996 Dec; 21(4-6):165-9. PubMed ID: 9300976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.